Our innovations are brought to life through risk-reward sharing partnerships

Our partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products we help develop. Using this approach, we focus on advancing promising therapeutic solutions, such as Virtue SAB and BackBeat CNT, through late-stage clinical research and regulatory approvals, while our partners focus on leveraging their commercial expertise and existing infrastructure to bring our products to global markets quickly and efficiently.

• Optimizing development and commercialization of product candidates by sharing of responsibilities, risks and rewards with partners
• Enhancing capital efficiencies by sharing costs and responsibilities with our partners
• Maximizing the potential of future profitability by creating multiple long-term royalty and revenue sharing arrangements with partners